Herrick, Feinstein LLP is proud to have represented Mediware Information Systems, Inc. (
), a leading provider of clinical software solutions, in reaching a merger agreement to be acquired by leading private equity investment firm Thoma Bravo, LLC. The transaction, which is subject to shareholder approval, is valued at approximately $195 million.
“Bringing Mediware together with Thoma Bravo will enable the company to build on its exceptional brand and reputation as a premier provider of medical technology management solutions, hopefully allowing it to expand its reach while continuing its record of excellent customer service,” said Irwin A. Kishner, Chairman of Herrick's Executive Committee and Co-Chairman of the firm's Corporate Department.
The Herrick deal team was led by Mr. Kishner and included Partners Stephen E. Fox and Harold Levine (tax) as well as Counsel Fred Green (benefits) and Sung Hwang (tax) and Associate Liliana Chang.
The merger is subject to standard closing conditions, regulatory approvals and the approval of Mediware shareholders. The Mediware board of directors has already unanimously approved the agreement. Under the terms of the pending agreement, shareholders will receive $22.00 in cash for each share of Mediware common stock. The transaction is expected to close before the end of the year.
Herrick’s Corporate Department has a track record of successes representing major clients across the country and around the world, including many Fortune 1000 firms. The firm’s clients include financial institutions, private equity firms, venture capital firms, hedge funds, investment banks and private investors on a full range of matters.
Founded in 1928, Herrick, Feinstein LLP is a prominent 165-lawyer firm providing a full range of legal services, including real estate, litigation, bankruptcy, employment, corporate, tax and personal planning, government relations, insurance and intellectual property law.